Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
Safer
Daniel J
DJ
Johns Hopkins University School of Medicine, Departments of Psychiatry and Pediatrics, Baltimore, Maryland, USA. dsafer@jhmi.edu
D000293:Adolescent; D000367:Age Factors; D001008:Anxiety Disorders / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors